Press Releases from Pancreatic Cancer (4 total)
Current Treatment Landscape, Unmet Needs, Pipeline And Commercial Opportunity In …
Researchmoz added Most up-to-date research on "Current Treatment Landscape, Unmet Needs, Pipeline And Commercial Opportunity In Pancreatic Cancer Market - Opportunity Analysis and Forecasts to 2017" to its huge collection of research reports.
With five-year survival only approximately 5%, pancreatic cancer is characterized as a disease with some of the highest unmet need in oncology. This report focuses on the current treatment landscape, unmet needs, pipeline and commercial opportunity in the…
Pancreatic Cancer Therapeutics Markets To Rise At A Moderate CAGR Of 7.6% From $ …
Researchmoz added Most up-to-date research on "Pancreatic Cancer Therapeutics Markets To Rise At A Moderate CAGR Of 7.6% From $1.746bn In 2014 To $2.92bn In 2021" to its huge collection of research reports.
Pancreatic Cancer (PC) is a disease predominately of the elderly with ~75% of PC cases being diagnosed in patient’s over 75 years old. PC proliferates rapidly, is asymptomatic at its earliest stages and when symptoms do present themselves…
Latest Research Report on Pancreatic Cancer - Identifying and Commercializing Fi …
Researchmoz added Most up-to-date research on "Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation" to its huge collection of research reports.
Pancreatic cancer is the 12th most common cancer globally, and the fourth most fatal, with a mortality rate of 10.9 deaths per 100,000 people per year. The poor prognosis of pancreatic cancer patients has highlighted a significant need for new and improved approaches to treatment, which is not…
Frontier Pharma: Pancreatic Cancer - Identifying And Commercializing First-In-Cl …
Pancreatic cancer is the 12th most common cancer globally, and the fourth most fatal, with a mortality rate of 10.9 deaths per 100,000 people per year. The poor prognosis of pancreatic cancer patients has highlighted a significant need for new and improved approaches to treatment, which is not being met by the current market.
A highly active pancreatic cancer pipeline contains an array of products with varying molecule types and mechanisms…
